Since the incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP), are major regulators of post-prandial insulin secretion, inhibition of DPP4 by the gliptin family of drugs has gained considerable interest for the therapy of type 2 diabetic patients
Does the loading phase cause more bloating
Each medication has a half-life how long it takes for half to clear your system: Semaglutide: ~7 days Tirzepatide: ~5 days As levels dip toward the end of the week, appetite and cravings can creep back
Wildenburg G et al
In the case of tirzepatide, these findings suggest that the medicine should be used with caution in people who are planning to get pregnant
[16] Monitoreo mdico recomendado: Evaluaciones iniciales (antes de iniciar): Hemoglobina A1C y glucosa en ayunas Panel metablico completo (funcin renal y heptica) Perfil lipdico Evaluacin de antecedentes de pancreatitis, enfermedad tiroidea o enfermedad gastrointestinal grave Revisin de medicamentos concomitantes Seguimiento durante el tratamiento: Primeras 4-8 semanas: Evaluacin de tolerabilidad y efectos secundarios Cada 3 meses: Medicin de HbA1c, peso corporal, presin arterial Cada 6-12 meses: Panel metablico completo, perfil lipdico Continuo: Monitoreo de sntomas gastrointestinales y ajuste de otros medicamentos para diabetes si es necesario Los pacientes que toman insulina o sulfonilureas pueden requerir reducciones de dosis de estos medicamentos para prevenir hipoglucemia